Call Now! 866-464-3202
This is a custom template (Home Pages: Video Center Area - AUTO PLAY WITH MUTED SOUND) that is currently displayed on the following pages: * third column

Video Center

Icagen, Inc. · Durham, NC United States ·(NASDAQ (GM): ICGN)

Company Description

4222 Emperor Blvd. Ste. 350
Durham, NC
27703
United States (Map)
Phone: 919-941-5206
Fax: 919-941-0813
    View Icagen, Inc. Locations On A US MapThis link will open in a new window

    Icagen wants to set the market for ion channel modulators on fire. The development-stage biotech focuses on treatments for epilepsy, asthma, pain, and inflammation by regulating the inflow into cells of such ions as calcium, potassium, and sodium. Icagen's lead candidate, senicapoc for sickle cell disease, died in 2007 following lackluster Phase III clinical trial results. The drug was being developed in a partnership with Johnson & Johnson subsidiary McNeil Consumer & Specialty Pharmaceuticals. Shortly thereafter Icagen announced a deal collaborating with Pfizer on the development of pain treatments. To read the full description, subscribe now.

    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!

    Key Icagen, Inc. Financials

    Company TypePublic - NASDAQ (GM): ICGN

    Single Location
    Fiscal Year-EndDecember
    2008 Sales (mil.)$12.3
    2008 Employees73

    Icagen, Inc. Executives

    15 executives listed for Icagen, Inc.'s Durham, NC location.
    TitleName & BioContact
    ChairmanCharles SandersNetwork
    President, CEO, and DirectorP. Kay WagonerNetwork
    EVP Finance and Corporate Development, CFO, and TreasurerRichard KatzNetwork

    Competition

    Competitive Landscape for Icagen, Inc.
    Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.
    Top Icagen, Inc. Competitors
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!